Northwest Biotherapeutics Stock Price on June 1, 2023

NWBO Stock  USD 0.27  0.01  3.85%   
If you're considering investing in Northwest OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Northwest Biotherapeutics stands at 0.27, as last reported on the 29th of December, with the highest price reaching 0.28 and the lowest price hitting 0.26 during the day. Northwest Biotherapeutics has Sharpe Ratio of -0.0448, which conveys that the firm had a -0.0448% return per unit of risk over the last 3 months. Northwest Biotherapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Northwest Biotherapeutics' Mean Deviation of 2.93, risk adjusted performance of (0.04), and Standard Deviation of 4.1 to check out the risk estimate we provide.
  
Northwest OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0448

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNWBO

Estimated Market Risk

 4.11
  actual daily
36
64% of assets are more volatile

Expected Return

 -0.18
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Northwest Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Northwest Biotherapeutics by adding Northwest Biotherapeutics to a well-diversified portfolio.

Northwest Biotherapeutics Valuation on June 1, 2023

It is possible to determine the worth of Northwest Biotherapeutics on a given historical date. On June 1, 2023 Northwest was worth 0.61 at the beginning of the trading date compared to the closed value of 0.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Northwest Biotherapeutics otc stock. Still, in general, we apply an absolute valuation method to find Northwest Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Northwest Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Northwest Biotherapeutics' related companies.
 Open High Low Close Volume
  0.59    0.63    0.59    0.60    1,152,300  
06/01/2023
  0.61    0.62    0.60    0.61    660,639  
  0.61    0.62    0.60    0.61    977,974  
Backtest Northwest Biotherapeutics  |  Northwest Biotherapeutics History  |  Northwest Biotherapeutics Valuation   PreviousNext  
Open Value
0.61
0.61
Closing Value
12.94
Upside

Northwest Biotherapeutics Trading Date Momentum on June 1, 2023

On June 02 2023 Northwest Biotherapeutics was traded for  0.61  at the closing time. The top price for the day was 0.62  and the lowest listed price was  0.60 . The trading volume for the day was 978 K. The trading history from June 2, 2023 did not cause price change. The trading delta at closing time against the current closing price is 21.31% .

Northwest Biotherapeutics Fundamentals Correlations and Trends

By evaluating Northwest Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Northwest Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Northwest financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Northwest Biotherapeutics OTC Stock history

Northwest Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Northwest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Northwest Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Northwest Biotherapeutics stock prices may prove useful in developing a viable investing in Northwest Biotherapeutics
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.

Northwest Biotherapeutics OTC Stock Technical Analysis

Northwest Biotherapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Northwest Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Northwest Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Northwest Biotherapeutics Period Price Range

Low
December 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Northwest Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Northwest Biotherapeutics December 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Northwest Biotherapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Northwest Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Northwest Biotherapeutics otc stock market strength indicators, traders can identify Northwest Biotherapeutics entry and exit signals to maximize returns

Northwest Biotherapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Northwest Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Northwest OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Northwest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Northwest OTC Stock

Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.